What is Aclarion?
Aclarion operates as a provider of conventional imaging solutions, specifically focusing on lumbar MRI for chronic lower back pain. The company has developed an evidence-supported, SaaS platform that utilizes MR Spectroscopy. This innovative technology enables physicians to noninvasively distinguish between painful and non-painful discs in the spine, offering a more precise diagnostic pathway than traditional methods. The company's focus on a critical unmet need in spine care positions it as a key player in medical technology innovation.
How much funding has Aclarion raised?
Aclarion has raised a total of $2.1M across 2 funding rounds:
Debt
$125K
Debt
$2M
Debt (2021): $125K with participation from PPP
Debt (2023): $2M, investors not publicly disclosed
Key Investors in Aclarion
PPP
Public-Private Partnership
What's next for Aclarion?
The recent major strategic investment suggests Aclarion is poised for significant scaling and market penetration. This backing will likely fuel further development of its MR Spectroscopy platform, enhance its SaaS infrastructure, and expand its reach to a broader physician network. The enterprise-level funding context indicates a transition towards broader commercialization and potentially new service offerings, solidifying its position in the competitive healthcare diagnostics landscape.
See full Aclarion company page
